The isolated Withaferin-A was screened for anticancer activity against
. When ranked within age groups, cancer is one of the five leading causes of death amongst both males and females and the single largest cause of death worldwide 3 . This growing trend indicates deficiency in the present cancer therapies which include surgical operation, radiotherapy and chemotherapy. At present, alkylating agents, antimetabolites, antitumor antibiotics, platinum analogs and natural anticancer agents are mostly used in cancer chemotherapy. Since the mortality rate in chemotherapy and radiation therapy is remarkably noticed, discovery of new anticancer agents derived from nature, especially plants, is currently under investigation 4, 5 . According to FDA approved anticancer preparations drugs of natural origin have a share of 60-75% 6 .
There are very effective cancer chemotherapeutic drugs that have been derived from natural origin 7 . Vinca alkaloids, vinblastine and vincristine have been reported as potent anticancer agents 8 . Paclitaxel (Taxol), originally isolated from the bark of the Pacific yew tree from the Pacific Northwest, Taxus brevifolia Nutt., and the analogue, docetaxel 9 etoposide and teniposide, derived semi synthetically from epipodophyllotoxin, an epimer of podophyllotoxin, isolated from roots of Podophyllum species 10 . Withania somnifera is a small, woody shrub which belongs to Solanaceae family. It is commonly known as Indian ginseng or Ashwagandha in Hindi. W. somnifera has been an important herb in the Ayurvedic and indigenous medical systems for over 3000 years. W. somnifera possesses a number of therapeutic actions which include anti-inflammatory, sedative, hypnotic, narcotic, general tonic, diuretic, aphrodisiac, alterative, deobstruent [11] [12] [13] [14] [15] [16] [17] [18] , uterine tonic and increases production of semen 12, 14, 15 . W. somnifera has been revealed as an immune stimulator in immune suppressed animal models 19 and also an immune regulator in immune inflammation animal models The active constituents of W. somnifera include alkaloids, Withanolide, saponins containing an additional acyl group, flavonoids, and tannins 21, 22, 23 . Over 130 Withanolide are known and more than 40 withanolides, 12 alkaloids, and several sitoindosides were isolated from different parts (leaves, roots and cherries) of W. somnifera and their structures were elucidated 24, 25, 26 . Withanolides are found mainly in leaves and account upto 0.5% dry weight of the plants depending on the different species [27] [28] [29] . More than 45 Withanolides, 5 unidentified alkaloids, many free amino acids, chlorogenic acid, glycosides, glucose, condensed tannins, and flavonoids have been reported in leaves of W. somnifera 30, 16 . Withaferin-A, a steroidal lactone is the most important withanolide isolated from the extract of the leaves and dried roots of Withania somnifera. Withaferin-A is one of the active constituent for curative properties of the leaves and roots 31 . Recent in vitro studies have revealed that Withaferin-A inhibit growth of breast and colon cancer cell lines more effectively than did doxorubicin. It suggests that W. somnifera extracts may be a potent anticancer agent 32 . This is an exciting finding, suggesting that Ashwagandha could enhance survival in individuals with cancer. Therefore, the present study was undertaken to test anti-cancer activity of isolated Withaferin-A against MCF-7, U373-MG and OVKAR-3 cancer cell lines.
MATERIALS AND METHODS

Extraction of the plant materials
Leaves of W. somnifera collected from Karnataka and Nimuch region were cleaned, air dried and crushed into coarse powder with mortar and pestle. 10 g of powdered leaves were extracted respectively with 160 ml of methanol for 36 hr using Soxhlet apparatus. The extracts were concentrated on water bath to 20 ml and stored in properly labeled clean, dry, screw capped bottles until use 33 .
HPTLC analysis Micro-Preparative chromatography
For Isolation of Withaferin-A from Withania somnifera of previously prepared 40 µl plant extracts were loaded as a 160-mm streak on HPTLC plate. The solvent system used was Chloroform: Methanol (9:1). After derivatization, the plates were dried and observed under 254 nm and 366 nm. Rf values, AUC and λ max of Withaferin-A of the samples were recorded. Withaferin-A band was removed and heated slightly in 2 ml methanol to make the compound diffuse into the solvent and stored overnight in a refrigerator. The following day isolated compound in methanol was filtered through Whatman filter paper 44 and used for analysis. Purity of compound was confirmed by comparing it with standard Withaferin-A and through Mass Spectra. Bulk Isolation of Withaferin-A For bulk isolation of Withaferin-A plant material from Karnataka and Nimuch regions was used since they showed higher quantity of compound. Isolation was performed using a modified method as below. 1 g of powdered leaf material of Withania somnifera from the selected regions was extracted three times by the liquid extraction method in an Erlenmeyer flask by shaking on a platform shaker (10-30 rpm) for 8 hrs. The solvent used for extraction was methanol: water (10:90). The extracts were recovered by filtration and the filtrates from three extraction system were pooled and liquid-liquid partitioned (three times) with (equal volume) n-hexane to remove pigments and fatty materials. The defatted and depigmented extract was subjected to liquid-liquid partitioning (3 times equal volume) to recover withanolidal fraction including Withaferin-A in the chloroform layer. Chloroform fraction of each extract was pooled and evaporated to dryness and was analyzed for anticancer screening 34 . The purity of isolated compound was confirmed by HPTLC.
Antiproliferative activity
The screening of anticancer activity of Withaferin-A isolated from leaves of W. somnifera from Karnataka (WSK-L) and Nimuch (WSN-L) was tested in-vitro by Sulforhodamine B (SRB) method on three Human cancer cell lines viz. MCF-7 (Human-breast adenocarcinoma), U373-MG (Nervous systemglioblastoma) and OVKAR-3 (ovary-Adenocarcinoma). The cell lines we obtained from NCI, USA and NCCS, Pune. Adriamycin was used as a positive control. The test parameters were LC50, TGI, and GI50.
Sulphorhodamine B (SRB) Assay
The selected cell lines viz. MCF-7, U373-MG and OVKAR-3 were grown in RPMI 1640 medium containing 10% fetal bovine serum and 2 mM L-glutamine. The cells were inoculated into 96 well micro titer plates in www.ijpbs.com or www.ijpbsonline.com
3 100 µl at plating densities. After cell inoculation, the micro titer plates were incubated at 37°C, 5 % CO2, 95 % air and 100 % relative humidity for 24 h prior to addition of experimental drugs. After incubation for 24 h, one 96 well plate containing 5X10 3 cells/well was fixed in situ with TCA, to represent a measurement of the cell population at the time of drug addition (Tz). Experimental drugs were initially solubilized in dimethyl sulfoxide at 100 mg/ml and diluted to 1mg/ml using water and stored frozen prior to use. At the time of drug addition, an aliquot of frozen concentrate (1mg/ml) was thawed and diluted to 100 μg/ml, 200 μg/ml, 400 μg/ml and 800 μg/ml with complete medium containing test article. Aliquots of 10 µl of these different drug dilutions were added to the appropriate micro titer wells already containing medium.
Endpoint Measurement:
After 48 hr incubation, the cells were fixed in situ by the gentle addition of 50 µl of cold 30 % (w/v) TCA (final concentration, 10 % TCA) and incubated for 60 minutes at 4°C. The supernatant was discarded and the plates were washed with tap water and air dried. The 50 µl of SRB solution (0.4 %) was added to each of the wells, and plates were incubated for 20 minutes at ambient temperature. After staining, unbound dye was recovered and the residual dye was removed by washing five times with 1 % acetic acid. The plates were air dried and 100 µl of 10 mM Tris base pH 10.5 (Sigma) were added to each well to solubilize the dye. Bound stain was subsequently eluted with 10 mM trizma base, and the absorbance was read on a plate reader at a wavelength of 540 nm with 690 nm reference wavelength. Cell survival was measured as the percentage absorbance compared to that of the control.
RESULT AND DISCUSSION
The plant biodiversity of India is rich source of natural. Medicinal plants can reduce the toxic side effects of chemotherapy and radiation treatment by reinforcing their killing action. Withaferin-A is one of the major secondary metabolites of W. somnifera. Witheferin-A is found maximum in the leaves of plant from Karnataka and Nimuch region 35 . Therefore, in present work, Withaferin-A was isolated from the plants grown in Karnataka and Nimuch region of India were tested for them against studied cell line.
Isolation and confirmation of Withaferin-A
Withaferin-A isolated by preparative HPTLC method from leaves was confirmed by comparing with the standard peak of Withaferin-A at 223 nm ( Fig.1-2 ) and Mass spectroscopy with molecular weight 471.6. Scan mode ES + 1.05e8. Moreover, the product ion mass spectra of m/z 471.6 clearly matched those of the standard which shows the product ion mass spectrum of Withaferin-A in the standard solution (40µg/ml) and in the sample (Fig.3) . . Withaferin has been quantified using HPTLC in microwave assisted solvent extraction in Withania somnifera 37 . HPTLC is found to be precise and accurate method to estimate the presence of Ashwagandha in herbal formulations (capsule) 38 .
Bulk Isolation of Withaferin-A
Withaferin-A was isolated in bulk from leaf samples of Karnataka and Nimuch by solvent extraction method 34 . The isolated Withaferin-A, was confirmed by comparing Rf of standard Withaferin-A using HPTLC. Anticancer activity of Withaferin-A Anticancer activity of isolated Withaferin-A tested on MCF-7. U373-MG, and OVKAR-3 % growth control, IC50, TGI and GI-50 were determined for each cell line tested. cancer cell lines were tested by Sulforhodamine B (SRB) assay. SRB assay seems to be a preferred method for determining the antiproliferative/ cytotoxicity activity of medicinal plant extracts 39 . SRB assay has been used 5 by several workers not only for Withania somnifera 40, 41 but also for other medicinal plants 42, 43 . Withaferin-A isolated sample gave better growth control result on MCF-7 cell line (Table 1; Fig.4) . The results obtained against U373-MG cell line gave GI50 values of <10, i.e. lower than standard Withaferin-A tested and at par with positive control (Table 2; Fig. 5 ).
Whereas results obtained in OVKAR-3 cell line were comparable to those obtained with standard Withaferin-A and Adriamycin control (<10ug/ml) ( Table  3 ; Fig.6 ). The antiproliferative activity in the crude extracts of W. somnifera is perhaps due to Withaferin-A and not Withanolide-A 44 . 
CONCLUSION
Withaferin-A isolated from Karnataka and Nimuch samples seemed to have potential anticancer activity against studied cell line viz. MCF-7. U373-MG, and OVKAR-3. These findings suggest that Withania somnifera plants cultivated in Nimuch and Karnataka can be exploited to produce novel medicines against this ailment. The present study can be used in future for economical formulations of the active chemical ingredients in natural drugs against cancer.
